PMV Pharmaceuticals, Inc. (PMVP)
1.37
+0.03
(+2.24%)
USD |
NASDAQ |
Sep 09, 16:00
1.37
0.00 (0.00%)
After-Hours: 17:07
PMV Pharmaceuticals Total Assets (Quarterly) : 82.07M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 82.07M |
| March 31, 2026 | 96.56M |
| December 31, 2025 | 116.56M |
| September 30, 2025 | 133.84M |
| June 30, 2025 | 152.86M |
| March 31, 2025 | 170.61M |
| December 31, 2024 | 191.29M |
| September 30, 2024 | 223.50M |
| June 30, 2024 | 237.54M |
| March 31, 2024 | 236.88M |
| December 31, 2023 | 252.15M |
| September 30, 2023 | 261.03M |
| June 30, 2023 | 242.22M |
| March 31, 2023 | 253.96M |
| Date | Value |
|---|---|
| December 31, 2022 | 270.31M |
| September 30, 2022 | 284.98M |
| June 30, 2022 | 300.56M |
| March 31, 2022 | 315.01M |
| December 31, 2021 | 331.57M |
| September 30, 2021 | 344.18M |
| June 30, 2021 | 355.91M |
| March 31, 2021 | 354.39M |
| December 31, 2020 | 365.53M |
| September 30, 2020 | 374.45M |
| June 30, 2020 | 89.10M |
| March 31, 2020 | |
| December 31, 2019 | 103.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.57M |
| Shareholders Equity (Quarterly) | 71.50M |
| Debt to Equity Ratio | 0.003 |
| Current Ratio | 7.703 |
| Net Debt Paydown Yield | 0.25% |